Effect of Phenylephrine on Cerebrovascular Regulation: A Translational Perspective

J Am Heart Assoc. 2025 Oct 7;14(19):e042396. doi: 10.1161/JAHA.125.042396. Epub 2025 Sep 25.

Abstract

Background: Phenylephrine is an alpha 1-adrenergic receptor (α1R) agonist. Evidence indicates activation of α1Rs can initiate both vasoconstrictor and dilator signaling. How phenylephrine affects cerebrovascular regulation remains unclear.

Methods: A retrospective analysis of data examining cerebral perfusion and blood pressure during systemic phenylephrine infusion in humans and swine was completed. Follow-up experiments examining cerebral hemodynamics during intracarotid arterial infusion of phenylephrine in anesthetized swine were performed. Ex vivo experiments were conducted on isolated porcine cerebral arteries.

Results: Systemic phenylephrine infusion increased indices of cerebrovascular resistance in both humans (P=0.0423) and swine (P<0.0001) but did not decrease perfusion. Intracarotid phenylephrine infusion did not alter cerebrovascular resistance, but increased perfusion in control conditions (P=0.0045), whereas resistance increased (P≤0.0155) without altered perfusion during NOS (nitric oxide synthase) inhibition conditions. α1Rs were detected on both extraluminal and intraluminal aspects of cerebral arteries, reflecting a population of vascular smooth muscle and endothelial α1Rs, respectively. Extraluminal phenylephrine caused vasoconstriction whereas intraluminal phenylephrine elicited an endothelium-dependent NO-mediated dilation. NOS inhibition enhanced phenylephrine-induced vasoconstriction in third-order branch of the middle cerebral artery, but not the first-order or second-order pial arteries (P=0.0267), and this corresponded with an increased ratio of phosphorylated to total endothelial NOS protein content in third-order versus first-order and second-order arteries (P≤0.0022). Phenylephrine-induced constriction was greatest in first-order arteries (P=0.0419), and this corresponded with increased perivascular adrenergic innervation and α1R protein content in first-order versus second-order and third-order arteries (P≤0.0054).

Conclusions: Neither systemic nor intracarotid phenylephrine infusion compromised cerebral perfusion, possibly related to increased endothelial NO signaling and reduced α1R density in downstream pial arteries.

Keywords: cerebrovascular; endothelium; nitric oxide; phenylephrine; α1‐adrenergic.

MeSH terms

  • Adrenergic alpha-1 Receptor Agonists* / administration & dosage
  • Adrenergic alpha-1 Receptor Agonists* / pharmacology
  • Adult
  • Animals
  • Cerebral Arteries* / drug effects
  • Cerebral Arteries* / metabolism
  • Cerebrovascular Circulation* / drug effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenylephrine* / administration & dosage
  • Phenylephrine* / pharmacology
  • Receptors, Adrenergic, alpha-1 / drug effects
  • Receptors, Adrenergic, alpha-1 / metabolism
  • Retrospective Studies
  • Swine
  • Translational Research, Biomedical
  • Vascular Resistance / drug effects
  • Vasoconstriction* / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation* / drug effects

Substances

  • Phenylephrine
  • Adrenergic alpha-1 Receptor Agonists
  • Receptors, Adrenergic, alpha-1
  • Vasoconstrictor Agents